Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04XYL
|
||||
| Former ID |
DNC002554
|
||||
| Drug Name |
2'3'-Dideoxyinosine
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Phase 2 | [521413] | ||
| Structure |
|
Download2D MOL |
|||
| Formula |
C10H12N4O3
|
||||
| Canonical SMILES |
C1CC(OC1CO)N2C=NC3=C2NC=NC3=O
|
||||
| InChI |
1S/C10H12N4O3/c15-3-6-1-2-7(17-6)14-5-13-8-9(14)11-4-12-10(8)16/h4-7,15H,1-3H2,(H,11,12,16)/t6-,7?/m0/s1
|
||||
| InChIKey |
BXZVVICBKDXVGW-PKPIPKONSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Purine nucleoside phosphorylase | Target Info | Inhibitor | [551393] | |
| BioCyc Pathway | Arsenate detoxification I (glutaredoxin) | ||||
| Purine nucleotides degradation | |||||
| Urate biosynthesis/inosine 5'-phosphate degradation | |||||
| Purine deoxyribonucleosides degradation | |||||
| Purine ribonucleosides degradation to ribose-1-phosphate | |||||
| Guanosine nucleotides degradation | |||||
| Adenosine nucleotides degradation | |||||
| Superpathway of purine nucleotide salvage | |||||
| Adenine and adenosine salvage III | |||||
| Guanine and guanosine salvage | |||||
| NetPath Pathway | TCR Signaling Pathway | ||||
| EGFR1 Signaling Pathway | |||||
| PathWhiz Pathway | Purine Metabolism | ||||
| Nicotinate and Nicotinamide Metabolism | |||||
| Reactome | Purine salvage | ||||
| Purine catabolism | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.